The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study
Table 4
Bivariate logistic regression models for dyspnea attributed to COVID-19.
Variables
Group NBT vs. BIO adjusted OR (95% CI)
value
Group TT vs. BIO adjusted OR (95% CI)
value
Confounder OR (95% CI)
value
Gender
1.76 (0.66–4.48)
0.242
0.60 (0.13–1.98)
0.446
1.45 (0.61–3.42)
0.39
Age
1.78 (0.66–4.58)
0.240
0.63 (0.14–2.10)
0.488
1.00 (0.97–1.04)
0.84
BMI
1.76 (0.66–4.48)
0.242
0.63 (0.14–2.09)
0.487
1.01 (0.90–1.14)
0.83
Hypertension
1.79 (0.66–4.62)
0.233
0.64 (0.14–2.15)
0.505
1.25 (0.27–4.22)
0.74
Smoking status
1.67 (0.62–4.26)
0.295
0.60 (0.13–1.98)
0.446
2.46 (0.94–7.67)
0.086
Vaccination
1.71 (0.63–4.36)
0.267
0.56 (0.12–1.86)
0.389
1.84 (0.62–4.85)
0.24
The value < 0.05 is considered significant. Abbreviations: BMI: body mass index, BIO: biologics, CI: confidence interval, NBT: nonbiological treatment, OR: odds ratio, and TT: topical treatment or without pharmacological therapy.
